CICícero Pinheiro Inácio

Cícero Pinheiro Inácio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cícero Pinheiro Inácio has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Review of Biotechnological Applications of Glomeromycota: Inoculum Production, Plant Performance, Environmental Management, and Metabolites

    by Cícero Pinheiro Inácio, Greicilene Maria Rodrigues Albuquerque, Maria Alice Ribeiro Alves, Isabelly Guimarães Silva, Geuda Barbosa da Silva, Delson Laranjeira, Rejane Pereira Neves

    Arbuscular mycorrhizal fungi (Glomeromycota) offer routes to inoculum production, crop management, phytomanagement of contaminated soils, and modulation of plant metabolites. This critical narrative review integrates 102 selected original studies, including genomic, physiological, transcriptomic, cultivation, and field research. Evidence is interpreted by fungal strain, host genotype, tissue, environment, and application-specific endpoint. Host-lipid transfer and asymbiotic propagation inform inoculum manufacture, but spore production remains distinct from infective potency, storage stability, and economic feasibility. Receptor signaling and functional nutrient-transport studies connect symbiotic establishment to resource exchange; stress experiments reveal context-dependent changes in water transport, ion homeostasis, photosynthesis, and oxidative regulation. Commercial-product variability, resident microbiota, pesticide exposure, and ecological responses constrain translation. Metal localization and transport studies distinguish retention, mobilization, and tolerance from contaminant removal. Plant-metabolite experiments demonstrate chemical modulation rather than direct fungal biosynthesis or therapeutic efficacy. Soil carbon and hydraulic responses further show that ecological benefits cannot be generalized across communities or substrates. Development should prioritize verified inocula, defined host × fungal strain × environment combinations, relevant controls, and repeatable field outcomes. The narrative design and author-proposed assessment framework covers a deployment protocol.

  • Open Access

    Uncommon aortic prosthesis vegetation due to Histoplasma capsulatum: clinical and laboratory aspects

    by Reginaldo Gonçalves de Lima-Neto, Moacir Batista Jucá, Tomaz Christiano de Albuquerque Gomes, Karla Roberta Soares Rodrigues, Cícero Pinheiro Inácio, Rejane Pereira Neves

  • Open Access

    Transforming Blood Infection Diagnostics: AI and Electronic Noses Target Candida

    by Michael L. Bastos, Christina Cox, Clayton A. Benevides, Cícero P. Inácio, Rejane P. Neves, Frederico D. de Menezes, Margaret V. Powers-Fletcher, Leandro M. Almeida

    Candidemia is a severe fungal bloodstream infection with high mortality rates, especially in immunocompromised patients. Traditional diagnostic methods, such as blood cultures, suffer from low sensitivity and long turnaround times, delaying targeted antifungal therapy. In this study, we explore the potential of electronic noses (e-noses) combined with artificial intelligence (AI) models to provide a rapid and accurate diagnosis of Candida infections directly from blood culture broth samples. Samples were analyzed using an e-nose, generating datasets that underwent preprocessing steps including outlier removal, cycle equalization, feature transformation, and optional oversampling to address species imbalances. To ensure clinical relevance, we employed a dual-scenario validation strategy, assessing both intrasample sensor stability and intersample biological generalization. We tested both traditional machine learning models and time-series classifiers, selecting models based on prior research and performance in similar tasks. The best-performing models were evaluated based on accuracy, precision, recall, F1-score, specificity, and computational efficiency. Results demonstrated that while the framework achieved >98% consistency in sensor stability tests, the support vector classifier (SVC) emerged as the most robust model for generalization, achieving statistical parity with complex time-series models like InceptionTime, but with significantly higher computational efficiency. This study highlights the feasibility of AI-enhanced e-noses for rapid Candida detection, offering a promising alternative to conventional diagnostics in clinical settings.


  • Antifungal Efficacy of Imidazo[1,2- a ]Pyrazine-Based Thiosemicarbazones and Thiazolidinediones Against Sporothrix Species

    by Reginaldo G Lima-Neto, Marlene Sa Neta, Carlos At Valeriano, Rejane P Neves, Armando M Lacerda, Claudia E Ferraz, Cícero P Inácio, Patrice Le Pape, Isabelle Ourliac-Garnier, Antônio R Faria, et al.

    Aim: To evaluate antifungal potential of 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine hybrids based on thiosemicarbazones and thiazolidinediones against pathogenic Sporothrix species. Methods: Antifung...


  • Breakthrough of Clinical Candida Cultures Identification Using the Analysis of Volatile Organic Compounds and Artificial Intelligence Methods

    by Maria C. A. Castro, Leandro M. Almeida, Renan Williams M. Ferreira, Clayton A. Benevides, Cleber Zanchettin, Frederico D. Menezes, Cicero P. Inacio, Reginlado G. de Lima-Neto, Jose Gilson A. T. Filho, Rejane P. Neves

    Infections triggered by fungi of the genus Candida are widely known, although the high incidence and mortality factors are still unclear. The classic methods of identifying Candida species are subject to errors, requiring new techniques with faster and more accurate performance. We present a study for identifying fungi species by analyzing volatile organic compounds of cultures acquired and interpreted using Electronic Nose and Artificial Intelligence methods. The proposed approach contributes to establishing an agile and appropriate treatment, reducing the complications of the disease and the number of deaths. We perform experiments with three species of Candida obtaining accuracy above 90% in the fungi identification. Therefore, future works are encouraged to deal with more types of fungi to help create a new identification methodology faster and more reliable using artificial intelligence methods.


  • Open Access

    RELEVÂNCIA DA TROMBOCITOPENIA EM NEONATOS COMO INDICADOR SUGESTIVO DE CANDIDEMIA

    by Roberta Clark Gomes, Cicero Pinheiro Inácio, Greicilene Maria Rodrigues Albuquerque, Danielle Patrícia Cerqueira Macêdo, Carolina Maria da Silva, Rejane Pereira Neves, Luciana Maria Delgado Romaguera

  • Open Access

    Modelo experimental in vitro de piedra branca e avaliação do perfil de susceptibilidade de Trichosporon frente a derivados de tiofeno-tiosemicarbazona (L10)

    by Isabella Macário Ferro Cavalcanti, Jean Arthur Lima Falcão, Ylanna Larissa Alves Ferreira, Cícero Pinheiro Inácio, Danielle Patrícia Cerqueira Macêdo, Cleide Clea Cunha Miranda, Rejane Pereira Neves

    O objetivo do presente estudo foi avaliar o potencial de patogenicidade in vitro e o perfil de susceptibilidade de isolados de Trichosporon spp. aos derivados de tiofeno-tiosemicarbazona (L10). Inicialmente, foi realizada uma revisão taxonômica de 3 isolados de Trichosporon spp. de importância clínica estocados na Micoteca URM da Universidade Federal de Pernambuco (UFPE). Posteriormente foi avaliada a capacidade dessas espécies de crescer in vitro em amostras de pelos saudáveis (isentos de tratamentos químicos), a 25 °C e a 37 °C durante um período de 10 dias. Após este período, foi realizado exame direto dos pelos, utilizando KOH a 10%, e cultura em meio Ágar Sabouraud com cloranfenicol das amostras que cresceram no pelo, assim como análises da macro e micromorfologia dessas espécies fúngicas. Por fim, o perfil de susceptibilidade in vitro dessas espécies fúngicas aos derivados de tiofeno-tiosemicarbazona (L10) de acordo com o Clinical and Laboratory Standards Institute (CLSI) foi realizado para determinar as concentrações inibitórias mínimas (CIMs) e as concentrações fungicidas mínimas (CFMs). Através do modelo experimental in vitro foi possível observar que as seguintes espécies: Trichosporon asahii, T. ovoides e T. cutaneum são agentes etiológicos da piedra branca e apresentam potencial patogênico mesmo em um modelo experimental in vitro e sem a necessidade de sinergismo com outros tipos de microrganismos. Através da análise do perfil de susceptibilidade in vitro foi possível observar que os novos derivados de tiofeno testados não são eficazes em combater o crescimento das espécies de Trichosporon avaliadas, sendo assim inadequados para o tratamento das manifestações clínicas observadas na piedra branca. Em conclusão, esse estudo mostrou que é possível cultivar Trichosporon em um modelo in vitro e que são necessárias buscas por outras abordagens terapêuticas eficazes para o combate de infecções causadas pelos fungos do gênero Trichosporon.


  • Open Access

    Distribuição, fatores de risco e suscetibilidade antifúngica de espécies Candida isoladas da corrente sanguínea de pacientes críticos

    by Maria da Conceição Alexandre Castro, Cícero Pinheiro Inácio, Reginaldo Gonçalves de Lima-Neto, Rejane Pereira Neves

    A candidemia é uma preocupação crescente em hospitais de todo o mundo, com distribuição de espécies de Candida não-albicans cada vez mais frequente em pacientes na UTI e alta taxa de mortalidade. Este estudo teve o objetivo de identificar as espécies de Candida, fatores de risco e taxas de resistência antifúngica no Estado do Rio Grande do Norte. Trata-se de um estudo transversal analítico descritivo, realizado de 2018 a 2020, com 50 pacientes internados em UTIs de três hospitais terciários, na cidade de Natal no Estado do Rio Grande do Norte. Não foram encontradas diferenças estatísticas relacionadas ao sexo, mas significância relacionada a faixa etária, principalmente nos menores de onze anos. C. albicans (48%), C. tropicalis (32%) e C. pelliculosa (6%) foram as mais prevalentes. Os principais fatores de risco para candidemia, entre os pacientes dos três hospitais foi o uso de sondagem vesical (94%), nutrição parenteral (84%), cateter venoso central (48%), corticoterapia (44%) e imunossupressão (44%). Quando comparados os casos de candidemia nos diferentes hospitais e apresentação das espécies de Candida, não houve diferença significativa na distribuição dos óbitos. Desta forma, especial atenção deve ser direcionada aqueles pacientes que apresentarem estes fatores de risco a fim de realizar uma terapia profilática prévia. O percentual de mortes foi de 16,67% no Hospital B e 25% no Hospital C, não obtivemos dados de óbito para os pacientes do Hospital A. Observou-se resistência de C. albicans a anidulafungina, micafungina, voriconazol e anfotericina B, bem como de C. tropicalis a estes dois últimos antifúngicos. C. pelliculosa também foi resistente ao voriconazol. Enquanto que C. parapsilosis e C. krusei apresentaram resistência à anidulafungina. A distribuição de espécies e susceptibilidade antifúngica de isolados de Candida provenientes de casos de candidemia trazem novas perspectivas ao entendimento desse grave panorama. Assim, fornece informações úteis sobre a epidemiologia, fatores de risco e padrão de susceptibilidade úteis para a seleção de agentes antifúngicos empíricos para pacientes com candidemia.

  • Correction to: Coccidioidomycosis in a Pediatric Patient

    by Reginaldo Gonçalves de Lima-Neto, Cícero Pinheiro Inácio, Ronyllton Brito Costa, Rossana de Aguiar Cordeiro, Wendell Wons Neves, Rejane Pereira Neves, Oliane Maria Correia Magalhães, Armando Marsden Lacerda Filho, Paulo Sergio Ramos de Araújo

  • Open Access

    Epidemiology and antifungal susceptibility patterns of Candida species in tertiary hospitals: Update on regional trends

    by Cicero Pinheiro Inácio, Fernanda Gomes Beserra, Cynthia Regina Pedrosa Soares, Luciana Maria Delgado Romaguera, Paulo Sergio Ramos de Araújo, Maria Daniela Silva Buonafina, Luiz Nascimento Araújo Neto, Dalmir Cavalcanti dos Santos, Rejane Pereira Neves

    Trends in epidemiology and antifungal susceptibility of Candida species in Brazil between 2019–2020 are reported. A total of 22 isolates diagnosed from candidemia episodes were analyzed. Candida species were identified by specie specific primer and/or sequencing of 28S rDNA. Antifungal susceptibility was determined by CLSI method. C. tropicalis accounted for 11 (50%) cases followed by C. albicans (n=5, 22.73%), C. parapsilosis (n=4, 18.19%), Issatchenkia orientalis (n= 1, 4.54%), and Saccharomyces cerevisiae (n= 1, 4.54%). All Candida isolates were susceptible to amphotericin B and micafungin, and one was dose-dependent to anidulafungin. Eight of 20 Candida isolates were resistant to fluconazole and four sensitive doses dependent. Sixteen of 20 Candida isolates were resistant to voriconazole, and one resistant and one sensitive dose-dependent on caspofungin. Besides, the respective MIC50 and MIC90 values ​​were calculated with fluconazole (MIC50 and MIC90 of 4 and 64µg/mL, respectively) and voriconazole (MIC50 and MIC90 of 16µg/mL) showing the lowest potencies. The spread of fluconazole-resistant in one of major concerns, especially to C. tropicalis. The high use of antifungal drug may be a possible cause related to this scenario. Thus, the susceptibility profile test may be used to know the best way to introduce appropriateness empirical antibiotics therapy. Changing trends in incidence and antifungal susceptibility patterns of six Candida species causing candidemia in Kuwait between 2006–2017 are reported. A total of 2075 isolates obtained from 1448 patients were analyzed. Identity of Candida species isolates was determined by phenotypic methods and confirmed by PCR amplification/PCR-sequencing of rDNA and/or MALDI-TOF MS. Antifungal susceptibility was determined by Etest. C. albicans accounted for 539 (37.22%) cases followed by C. parapsilosis (n = 502, 34.67%), C. tropicalis (n = 210, 14.5%), C. glabrata (n = 148, 10.22%), C. krusei (n = 27, 1.81%) and C. dubliniensis (n = 22, 1.5%). The comparative percent distribution of Candida species causing candidemia between 2006–2011 and 2012–2017 was as follows: C. albicans 41.8% and 33.1%, C. parapsilosis complex 32.01% and 37.04%, C. tropicalis 13.59% and 15.31%, and C. glabrata 8.77% and 11.51%, C. krusei 2.0% and 1.7%, and C. dubliniensis 1.75 and 1.3%, respectively. Three of 371 C. albicans isolates during 2006–2011 and five of 363 during 2012–2017 were resistant to fluconazole. Among C. parapsilosis isolates, one of 310 during 2006–2011 and 21 of 446 during 2012–2017 were resistant to this drug. Furthermore, at an epidemiologic cutoff value (ECV) of ≤0.5 μg/ml, 70.1% C. albicans isolates were wild-type for fluconazole during 2006–2011 as compared to 58.1% during 2012–2017. Likewise, at an ECV of ≤2 μg/ml, 98.0% of C. parapsilosis isolates were wild-type during 2006–2011 as compared to 93.4% during 2012–2017. Clonal spread of fluconazole-resistant C. parapsilosis in one major hospital was documented. An 8.8% shift in favor of non-albicans Candida species with concomitant increase in MICs between the two periods preludes emergence of fluconazole-resistant candidemia cases in Kuwait.Changing trends in incidence and antifungal susceptibility patterns of six Candida species causing candidemia in Kuwait between 2006–2017 are reported. A total of 2075 isolates obtained from 1448 patients were analyzed. Identity of Candida species isolates was determined by phenotypic methods and confirmed by PCR amplification/PCR-sequencing of rDNA and/or MALDI-TOF MS. Antifungal susceptibility was determined by Etest. C. albicans accounted for 539 (37.22%) cases followed by C. parapsilosis (n = 502, 34.67%), C. tropicalis (n = 210, 14.5%), C. glabrata (n = 148, 10.22%), C. krusei (n = 27, 1.81%) and C. dubliniensis (n = 22, 1.5%). The comparative percent distribution of Candida species causing candidemia between 2006–2011 and 2012–2017 was as follows: C. albicans 41.8% and 33.1%, C. parapsilosis complex 32.01% and 37.04%, C. tropicalis 13.59% and 15.31%, and C. glabrata 8.77% and 11.51%, C. krusei 2.0% and 1.7%, and C. dubliniensis 1.75 and 1.3%, respectively. Three of 371 C. albicans isolates during 2006–2011 and five of 363 during 2012–2017 were resistant to fluconazole. Among C. parapsilosis isolates, one of 310 during 2006–2011 and 21 of 446 during 2012–2017 were resistant to this drug. Furthermore, at an epidemiologic cutoff value (ECV) of ≤0.5 μg/ml, 70.1% C. albicans isolates were wild-type for fluconazole during 2006–2011 as compared to 58.1% during 2012–2017. Likewise, at an ECV of ≤2 μg/ml, 98.0% of C. parapsilosis isolates were wild-type during 2006–2011 as compared to 93.4% during 2012–2017. Clonal spread of fluconazole-resistant C. parapsilosis in one major hospital was documented. An 8.8% shift in favor of non-albicans Candida species with concomitant increase in MICs between the two periods preludes emergence of fluconazole-resistant candidemia cases in Kuwait.